a.weiss

TL2 · Rennes

Contributes reviews on supplier material. Based in Rennes.

Joined 25 February 2025 · last posted 12h

90Posts here

2Topics

0Solutions

1.1kLikes received

1kLikes given

22Badges

259Days visited

4.9kPosts read

Recent activity

Full stream

Common supplements people ask about, assessed one at a time Replied, post #108 · Practice › Interactions · 27 Jul 2026 · 10 likes Clear enough that I do not think I have a follow-up, which is unusual.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #102 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 28 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
Journal club: what we got wrong in an earlier session Replied, post #114 · Evidence › Journal club · 23 Jul 2026 · 23 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
NHS criteria and how they are applied in practice Replied, post #37 · Regional › UK & Ireland · 21 Jul 2026 · 12 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
Coming back to: Telehealth prescribing models in the US Replied, post #23 · Regional › North America · 21 Jul 2026 · 15 likes Formulary position changes on a schedule that is published in advance, which means a decision made now may be answering last year's formulary. The claim is narrower…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #42 · Compounds › Repair & healing peptides · 20 Jul 2026 · 16 likes Anecdote is the whole of the human evidence base here, and this community's convention is to say so rather than to aggregate anecdotes into something that sounds like…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #36 · Practice › Dosing & titration · 20 Jul 2026 · 10 likes On four-week escalation interval: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #88 · Evidence › Journal club · 20 Jul 2026 · 0 likes Source for the SUSTAIN 6 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #52 · Practice › Interactions · 16 Jul 2026 · 2 likes Picking up post #51: that is the part I would want checked first. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #134 · Sourcing › Logistics · 14 Jul 2026 · 11 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #62 · Practice › Dosing & titration · 12 Jul 2026 · 6 likes On post #60 — agreed on the reasoning, with one qualification. The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #25 · Evidence › Meta-analyses · 11 Jul 2026 · 0 likes What I would check first on Risk-of-bias tools is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.